Anxiety & Medical Cannabis

Anxiety as a Qualifying Condition

Anxiety disorders affect tens of millions of Americans and are among the most undertreated conditions in medicine. Generalized anxiety disorder (GAD), panic disorder, social anxiety disorder, and related conditions can be debilitating — disrupting sleep, relationships, work, and basic functioning — even when they don't look severe from the outside.

A diagnosis of anxiety qualifies for New Jersey's medical cannabis program. Many patients come to us after medications, therapy, or both haven't been enough, but you don't have to have tried everything first.

Do I Have to Have Tried Other Treatments?

No. A documented anxiety diagnosis is what qualifies. Your provider will ask what you've tried, because it helps them judge whether cannabis fits your situation. Many patients who come to us are on medications that take the edge off but don't fully control their symptoms, or who experience significant side effects from their current treatment.

How Cannabis May Help

The endocannabinoid system plays a well-documented role in anxiety regulation. CBD (cannabidiol), in particular, has demonstrated anxiolytic effects in numerous clinical studies, with a favorable side effect profile compared to benzodiazepines and some antidepressants. Lower-dose THC can also reduce anxiety, though higher doses may paradoxically increase it in some patients — which is why physician guidance on product selection and dosing is critical.

PremierMD providers are experienced in tailoring cannabis recommendations for anxiety patients, with particular attention to CBD:THC ratios, starting doses, and delivery methods that minimize the risk of anxiety-worsening side effects.

Important: Anxiety and Depression

Many patients with anxiety also experience depression. Depression is not currently a qualifying condition under the NJ Medical Marijuana Program. However, if you are struggling with both conditions, our sister practice QuietMind Health provides psychiatric medication management and may be able to address both needs. For treatment-resistant depression specifically, Spravato NJ offers esketamine treatment.